Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malignant Melanoma

  Free Subscription

Articles published in
Cutis
    February 2024
  1. NGO BT
    Skin Cancer Screening: The Paradox of Melanoma and Improved All-Cause Mortality.
    Cutis. 2024;113:94-96.
    >> Share

    January 2024
  2. MANIACI JL, Raghavan SS
    PRAME Expression in Melanocytic Proliferations in Special Sites.
    Cutis. 2024;113:43-47.
    >> Share

    November 2023
  3. WHITE KD, Kerkvliet AM, Jassim AD
    Aberrant Expression of CD56 in Metastatic Malignant Melanoma.
    Cutis. 2023;112:E13-E15.
    >> Share

  4. SHAFI S, Challa B, Parwani AV, Aung TN, et al
    New Therapies in Melanoma: Current Trends, Evolving Paradigms, and Future Perspectives.
    Cutis. 2023;112:E32-E39.
    >> Share

    September 2023
  5. BORMANN JL, Kerkvliet AM
    Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors.
    Cutis. 2023;112:E17-E20.
    >> Share

    May 2023
  6. SULLIVAN DY, Sakamoto GK
    Eruptive Keratoacanthomas After Nivolumab Treatment of Stage III Melanoma.
    Cutis. 2023;111:E13-E15.
    >> Share

  7. ANDERSON JM, Tejani I, Jarmain T, Kellett L, et al
    Artificial Intelligence vs Medical Providers in the Dermoscopic Diagnosis of Melanoma.
    Cutis. 2023;111:254-258.
    >> Share

  8. MASSON R, Kwong A, Chen A, Barajas G, et al
    Disparities in Melanoma Demographics, Tumor Stage, and Metastases in Hispanic and Latino Patients: A Retrospective Study.
    Cutis. 2023;111:245-246.
    >> Share

  9. NGO BT
    Gene Expression Profiling for Melanoma Prognosis: Going Beyond What We See With Our Eyes.
    Cutis. 2023;111:222-223.
    >> Share

  10. LOGAN S, Shinohara MM
    Acral Necrosis After PD-L1 Immune Checkpoint Inhibitor Therapy.
    Cutis. 2023;111:E16-E17.
    >> Share

    April 2023
  11. KIPERS TG, Mullen HEK, Blumetti B
    Acute Onset of Vitiligolike Depigmentation After Nivolumab Therapy for Systemic Melanoma.
    Cutis. 2023;111:E15-E18.
    >> Share

    March 2023
  12. LY S, Rollins B, Mohr K, Jennings T, et al
    Hair Repigmentation as a Melanoma Warning Sign.
    Cutis. 2023;111:E18-E21.
    >> Share

    January 2023
  13. SABLE KA, Shields BE
    The Role of Dietary Antioxidants in Melanoma and Nonmelanoma Skin Cancer.
    Cutis. 2023;111:33-48.
    >> Share

    November 2022
  14. COKER HB 4TH, Mountcastle EA
    Primary Malignant Melanoma of the Middle Ear.
    Cutis. 2022;110:E12-E14.
    >> Share

    October 2022
  15. ALBERT NM, Gaddi A, Klawonn MA, Helm L, et al
    Genital Lentiginosis: A Benign Pigmentary Abnormality Often Raising Concern for Melanoma.
    Cutis. 2022;110:E36-E38.
    >> Share

    September 2022
  16. PATEL K, Sanchez IM, Nguyen JC, Chan LS, et al
    Disparities of Cutaneous Malignancies in the US Military.
    Cutis. 2022;110:132-136.
    >> Share

  17. LALLA SC, Kumar AB, Lehman JS, Lohse CM, et al
    Association of BRAF V600E Status of Incident Melanoma and Risk for a Second Primary Malignancy: A Population-Based Study.
    Cutis. 2022;110:150-154.
    >> Share

    August 2022
  18. SAX J, Lamerson C
    Ultra-Late Cutaneous Melanoma Recurrence Following 49 Years of Quiescence.
    Cutis. 2022;110:E53-E55.
    >> Share

    May 2022
  19. USATINE RP, Heath CR
    Melanoma.
    Cutis. 2022;109:284-285.
    >> Share

  20. HENRY W, Nash S, Pemberton J
    Conjunctival Melanoma of the Left Lower Eyelid.
    Cutis. 2022;109:E25-E27.
    >> Share

  21. KARAARSLAN I, Ozdemir F, Yaman B, Acar A, et al
    Reflectance Confocal Microscopy Findings in a Small-Diameter Invasive Melanoma.
    Cutis. 2022;109:269-271.
    >> Share

  22. HARVEY JA, Lehman JS, Lohse CM, Chamberlain AM, et al
    BRAF V600E Expression in Primary Melanoma and Its Association With Death: A Population-Based, Retrospective, Cross-Sectional Study.
    Cutis. 2022;109:279-283.
    >> Share

    June 2021
  23. FAWAZ B, Halpern A
    Nivolumab-Induced Granuloma Annulare.
    Cutis. 2021;107:E2-E4.
    >> Share

    May 2021
  24. STOKAR E, Rodriguez C, Feldman J
    Desmoplastic Melanoma Masquerading as Neurofibroma.
    Cutis. 2021;107:258-260.
    >> Share

  25. TSCHEN J, Davies P, Meek SM, Clarke LE, et al
    Clinical Use of a Diagnostic Gene Expression Signature for Melanocytic Neoplasms.
    Cutis. 2021;107:264-269.
    >> Share

    April 2021
  26. ELIAS ML, John AM, Maddukuri S, Schwartz RA, et al
    Treatment Delay in Melanoma: A Risk Factor Analysis of an Impending Crisis.
    Cutis. 2021;107:E19-E26.
    >> Share

  27. KORNREICH D, Saedi N
    Home Treatment of Presumed Melanocytic Nevus With Frankincense.
    Cutis. 2021;107:E56-E57.
    >> Share

    January 2021
  28. GALL R, Bongiorno M, Handfield K
    Skin cancer in the US Military.
    Cutis. 2021;107:29-33.
    >> Share

    November 2020
  29. HAMIDI S, Kim GH, DeClerck BK
    Multiple glomangiomas in a patient with a history of metastatic melanoma.
    Cutis. 2020;106:E20-E22.
    >> Share

    January 2020
  30. CONDIE D, Fathi R, Nijhawan RI
    Cartilage sutures for a large nasal defect.
    Cutis. 2020;105:44-45.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016